These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16751314)

  • 1. Efficacy of moxidectin 2 per cent oral gel against cyathostomins, particularly third-stage inhibited larvae, in horses.
    Bairden K; Davies HS; Gibson NR; Hood AJ; Parker LD
    Vet Rec; 2006 Jun; 158(22):766-7. PubMed ID: 16751314
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of moxidectin with ivermectin and pyrantel embonate for reduction of faecal egg counts in horses.
    Taylor SM; Kenny J
    Vet Rec; 1995 Nov; 137(20):516-8. PubMed ID: 8588278
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistence of the efficacy of a moxidectin gel on the establishment of cyathostominae in horses.
    Vercruysse J; Eysker M; Demeulenaere D; Smets K; Dorny P
    Vet Rec; 1998 Sep; 143(11):307-9. PubMed ID: 9789349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthelmintic therapy of equine cyathostomin nematodes - larvicidal efficacy, egg reappearance period, and drug resistance.
    Bellaw JL; Krebs K; Reinemeyer CR; Norris JK; Scare JA; Pagano S; Nielsen MK
    Int J Parasitol; 2018 Feb; 48(2):97-105. PubMed ID: 29050919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of moxidectin against cyathostomins after long-term use in a large herd of draught horses with a high stocking density.
    Schumacher J; Livesey L; DeGraves F; Blagburn B; Ziska S; Caldwell M; Brock K
    Vet Rec; 2009 May; 164(21):652-4. PubMed ID: 19465754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the mucosal inflammatory responses to equine cyathostomins in response to anthelmintic treatment.
    Steuer AE; Loynachan AT; Nielsen MK
    Vet Immunol Immunopathol; 2018 May; 199():1-7. PubMed ID: 29678224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of moxidectin 2% oral gel against second- and third-instar Gasterophilus intestinalis De Geer.
    Scholl PJ; Chapman MR; French DD; Klei TR
    J Parasitol; 1998 Jun; 84(3):656-7. PubMed ID: 9645883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of selected anthelmintic drugs against cyathostomins in horses in the federal state of Brandenburg, Germany.
    Fischer JK; Hinney B; Denwood MJ; Traversa D; von Samson-Himmelstjerna G; Clausen PH
    Parasitol Res; 2015 Dec; 114(12):4441-50. PubMed ID: 26337266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of nematode infections in horses.
    Coles G; Rhodes A
    Vet Rec; 2005 Jul; 157(4):123. PubMed ID: 16040950
    [No Abstract]   [Full Text] [Related]  

  • 10. Controlled dose confirmation study of a 2% moxidectin equine gel against equine internal parasites in The Netherlands.
    Eysker M; Boersema JH; Grinwis GC; Kooyman FN; Poot J
    Vet Parasitol; 1997 Jun; 70(1-3):165-73. PubMed ID: 9195720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationships between faecal egg counts and gut microbial composition in UK Thoroughbreds infected by cyathostomins.
    Peachey LE; Molena RA; Jenkins TP; Di Cesare A; Traversa D; Hodgkinson JE; Cantacessi C
    Int J Parasitol; 2018 May; 48(6):403-412. PubMed ID: 29432771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis.
    Heuer L; Petry G; Pollmeier M; Schaper R; Deuster K; Schmidt H; Blazejak K; Strube C; Di Cesare A; Traversa D; Schnyder M; McKay-Demeler J; von Samson-Himmelstjerna G; Mangold-Gehring S; Böhm C
    Parasit Vectors; 2020 Feb; 13(1):65. PubMed ID: 32051008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine cyathostomins.
    Matthews JB; Dowdall SM; Baudena MA; Klei TR; Kaplan RM; von Samson-Himmelstjerna G; Drögemüller M; Schnieder T
    Vet Parasitol; 2004 Oct; 125(1-2):203-20. PubMed ID: 24937879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum.
    Böhm C; Petry G; Schmidt H; Raue K; Barthel F; Schaper R
    Parasitol Res; 2017 Aug; 116(Suppl 1):1-10. PubMed ID: 28717944
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of moxidectin against bots and lungworm in equids.
    Coles GC; Hillyer MH; Taylor FG; Parker LD
    Vet Rec; 1998 Aug; 143(6):169-70. PubMed ID: 9746948
    [No Abstract]   [Full Text] [Related]  

  • 16. Verminous encephalitis in a horse produced by nematodes in the family protostrongylidae.
    Tanabe M; Kelly R; de Lahunta A; Duffy MS; Wade SE; Divers TJ
    Vet Pathol; 2007 Jan; 44(1):119-22. PubMed ID: 17197637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of anthelmintic resistance in cyathostomes: will it occur with the avermectin/milbemycins?
    Sangster NC
    Vet Parasitol; 1999 Aug; 85(2-3):189-201; discussion 201-4, 215-25. PubMed ID: 10485365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of ivermectin efficacy against cyathostomins and Parascaris equorum on horse farms using selective therapy.
    Larsen ML; Ritz C; Petersen SL; Nielsen MK
    Vet J; 2011 Apr; 188(1):44-7. PubMed ID: 20385508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a moxidectin/imidacloprid spot-on formulation (Advocate
    Diakou A; Morelli S; Dimzas D; Di Cesare A; Capelli G; Parrinello C; Pollmeier M; Schaper R; Traversa D
    Parasit Vectors; 2019 Nov; 12(1):519. PubMed ID: 31685011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ivermectin at an elevated dose against encysted equine cyathostome larvae.
    Klei TR; Chapman MR; French DD; Taylor HW
    Vet Parasitol; 1993 Mar; 47(1-2):99-106. PubMed ID: 8493773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.